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ABSTRACT 
 
Elizabeth Danielle Reese: The Trajectory of Distress Tolerance Following Substance Use 
Treatment 
(Under the direction of Stacey B. Daughters) 
 
 Distress tolerance (DT), defined separately as the actual or perceived ability to withstand 
aversive affective states, has been linked to problematic substance use behavior within 
nonclinical samples and treatment outcome among those with substance use disorders. Thus, DT 
may represent an important risk factor for substance use relapse, and has been evaluated as a 
target of substance use treatment. However, the longitudinal trajectory of DT among treatment 
seeking substance users remains unknown. The aims of the current study were to (a) characterize 
trajectories of perceived DT, assessed via self-report, and behavioral DT, assessed using a 
behavioral task, and (b) evaluate the influence of abstinence duration and frequency of use as 
predictors of DT change in a sample of residential treatment seeking substance users. Results of 
latent curve model analyses revealed that both perceived and behavioral DT improved 
nonlinearly over time. Additionally, abstinence duration was associated with greater 
improvement in both perceived and behavioral DT, and greater frequency of use post-treatment 
was associated with attenuated behavioral, but not perceived, DT. The current study provides 
evidence for naturally occurring improvement in both perceived and behavioral DT over 12 
months following completion of residential substance use treatment. Such findings provide 
support for the conceptualization of DT as a malleable treatment target and emphasize the 
importance of abstinence in DT improvement and substance use recovery.   
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CHAPTER 1: INTRODUCTION 
The negative reinforcement theory of addiction maintains that substance use functions to 
alleviate the aversive physiological and affective symptoms associated with withdrawal from 
substance use (Baker, Piper, McCarthy, Majeskie, & Fiore, 2004; Koob & Le Moal, 1997), 
thereby providing increased motivation for repeated use (Koob & LeMoal, 2001). To test this 
theory, researchers have quantified an individual’s distress tolerance (DT), operationalized both 
as behavioral capacity to persist towards a goal despite psychological or physical discomfort 
(behavioral DT; e.g., completing a difficult task in order to obtain reward), or as an individual’s 
perceived capacity to withstand aversive physical or psychological states (perceived DT). In 
doing so, substance use researchers can use DT as the conceptual approximation of a substance 
user’s ability to remain abstinent, a difficult undertaking that treatment-seeking substance users 
are highly motivated to pursue despite aversive physical or psychological states present in the 
early stages of abstinence (i.e., during withdrawal from substances).  In support of this 
conceptualization, low DT has been linked to problematic substance use among non-clinical 
samples (Ali, Ryan, Beck, & Daughters, 2013; Buckner, Keough, & Schmidt, 2007; Hasan, 
Babson, Banducci, & Bonn-Miller, 2015; Simons & Gaher, 2005), and both early relapse 
(Brown, Lejuez, Kahler, & Strong, 2002; Cameron, Reed, & Ninnemann, 2013; Daughters, 
Lejuez, Kahler, Strong, & Brown, 2005; Strong et al., 2012), and treatment dropout (Brandon et 
al., 2003; Daughters et al., 2005; Tull, Gratz, Coffey, Weiss, & McDermott, 2013) among those 
with substance use disorders (SUD).  Such findings support the notion that DT may represent an 
important risk factor for substance use relapse and treatment outcomes (Trafton & Gifford, 2010) 
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and as such, DT-specific interventions have been developed and evaluated for SUD and show 
promising results (e.g., Bornovalova, Gratz, Daughters, Hunt, & Lejuez, 2012; Brown et al., 
2008; Brown et al., 2013). Despite such promising work, methodologically relevant concerns 
prohibit a comprehensive understanding of DT within this population. Specifically, research 
investigating the associations of DT and substance use originates from both self-report (e.g., 
Distress Tolerance Scale; Simons & Gaher, 2005 ; Discomfort Intolerance Scale; Schmidt, 
Richey, & Fitzpatrick, 2006) and behavioral measures (e.g., Paced Auditory Serial Addition 
Task- PASAT; Lejuez, Kahler, & Brown, 2003; Mirror Tracing Persistence Task-Computerized 
Version MTPT-C; Daughters et al., 2005), which are thought to represent fundamentally 
separable constructs as they are repeatedly weakly correlated with one another across studies 
(Glassman et al., 2015; Kiselica, Rojas, Bornovalova, & Dube, 2015; McHugh et al., 2011). In 
addition, there is not clear consensus among researchers if an individual’s perceived and actual 
ability to tolerate distress (hereafter referred to respectively as perceived and behavioral DT) 
represent temporally stable constructs versus malleable mechanisms of change leading to 
improvement in SUD treatment outcome (Leyro, Zvolensky, & Bernstein, 2010; Zvolensky, 
Vujanovic, Bernstein, & Leyro, 2010).  
DT change in substance users 
DT treatment studies provide some evidence for the malleability of DT, both perceived 
and behavioral, among substance users. In line with the negative reinforcement theory of 
addiction, DT treatments work to provide individuals with skills to tolerate aversive 
psychological and physical symptoms during the recovery process. Specifically, increases in 
behavioral DT were observed as a function of treatment among polysubstance users in residential 
treatment (Bornovalova et al., 2012), and analyses of pilot data from five opiate dependent 
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individuals suggested an increase in perceived DT with DT-targeted treatment (Brown et al., 
2014). Such evidence is preliminary and focused on change specifically related to DT-targeted 
treatment. However, the extent to which DT naturally changes over time among substance users 
remains unknown. Relatedly, the dearth of information within DT treatment studies on DT 
change as a result of targeted treatment and the relationship between this change and substance 
use is notable. In particular, it’s unclear how both perceived and behavioral DT change may 
relate to important aspects of substance use, specifically abstinence duration and severity of 
continued substance use within this population.  
Fortunately, related work can inform theoretically based, data driven hypotheses 
concerning these processes. For example, research suggests multiple cognitive and 
neurobiologically based processes such as executive control and inhibition of emotion-driven 
responses contribute to one’s ability to successfully tolerate distress in pursuit of a larger goal 
(Trafton & Gifford, 2010). Such conceptualizations are supported by recent work showing 
aberrant activity in neural regions associated with these processes, including less activation in 
prefrontal cortical regions associated with cognitive control and emotion regulation and less de-
activation in emotion related regions such as the amygdala, in substance users performing a 
behavioral DT task as compared to healthy controls (Daughters et al., 2016). Relatedly, higher 
frequency of substance use has been shown to predict increased anxiety is response to stress 
(Fox, Axelrod, Paliwal, Sleeper, & Sinha, 2005), greater deficits in perceived DT (Buckner, 
Jeffries, Terlecki, & Ecker, 2016), and impairment in processes related to behavioral DT 
(Dahlgren, Sagar, Racine, Dreman, & Gruber, 2016; Wang et al., 2017). Alternatively, during 
periods of abstinence, substance users show significant improvements in neural structure and 
function across studies in regions associated with cognitive processes including behavioral 
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monitoring and response inhibition (for review, see Garavan, Brennan, Hester, & Whelan, 2013). 
Taken together research suggests that substance use influences both cognitive and 
neurobiological processes underlying DT, while abstinence allows for the recovery of such 
processes. Thus, it is likely that the trajectory of DT change among substance users may be 
influenced by multiple factors, including abstinence and severity of use. 
Current Study 
  As such, the aims of the current study were twofold. First, we sought to examine the 
natural temporal trajectory of perceived and behavioral DT among residential treatment seeking 
substance users at five assessment time points from pretreatment to 12-months post treatment. 
We hypothesized that both perceived and behavioral DT would increase over time. Second, we 
wanted to examine the influence of both abstinence and severity of substance use on the 
trajectory of behavioral and perceived DT. Consistent with previous work, we hypothesized that 
greater improvements in both behavioral and perceived DT would be associated with a longer 
abstinence duration and lower frequency of substance use.  
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CHAPTER 2: METHODS 
Participants 
 The study sample consisted of 263 individuals receiving residential substance use 
treatment in a large urban area. Of these, 70.7% (n = 186) were male, 94.73% were African 
American (n = 249), 3% Caucasian (n = 8), 1.9% Native American/American Indian (n = 5) and 
0.4% Asian (n = 1). Additionally, 192 (73%) individuals had at least a high school education or 
GED, and 213 (80.99%) were unemployed. The mean age of the sample was 42.68 years (SD = 
11.76). Current DSM-IV substance dependence diagnoses included cocaine (n = 86; 32.70%) 
alcohol (n = 81; 30.80%), hallucinogen (n = 37, 14.07%), opioid (n = 31; 11.79%), marijuana (n 
= 28; 10.65%), and sedative (n = 2; 0.8%) with 25.1% (n = 66) meeting dependence criteria for 
more than one substance.  
Procedure 
Data for this study was part of a larger project assessing the efficacy of a behavioral 
activation treatment for substance use as compared to a contact time matched control condition 
(Daughters et al., 2017). Adults between the ages of 18 and 65 years of age were approached by 
research staff and assessed for study eligibility within one week of treatment entry. Participants 
were excluded if they (1) endorsed current psychotic symptoms, (2) evidenced impaired 
cognitive ability or (3) had less than 30 days remaining in the residential facility indicating 
insufficient time to complete the study treatment before discharge. Eligible and interested 
participants provided informed consent and were subsequently randomized to a treatment 
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condition (i.e., behavioral activation versus supportive counseling). Detailed study recruitment, 
flow, screening, and randomization procedures are published elsewhere (Daughters et al., 2017).   
Study assessments occurred at pretreatment (T1), discharge from treatment (T2), 3-months 
post-treatment (T3), 6-months post-treatment (T4), and 12-months post-treatment (T5). 
Assessments consisted of interview, self-report, and computerized behavioral tasks. Upon 
completion of each assessment, participants were debriefed and compensated for study 
participation. All study-related procedures were approved by the University Institutional Review 
Board. 
Measures  
Sample Characteristics  
During the pre-treatment assessment, all participants completed a self-report 
demographic questionnaire to assess age, sex, ethnicity, education, and employment status. In 
addition, DSM-IV substance dependence was assessed at pre-treatment using the SCID-NP 
(First, Spitzer, Gibbon & Williams, 1995).  
Mirror Tracing Persistence Test -- Computerized version (MTPT-C; Daughters et al., 2005) 
Behavioral DT was assessed using the MTPT-C, a computer-adapted version of the 
original Mirror-tracing Persistence Task (MTPT; Quinn, Brandon, & Copeland, 1996). During 
this task, participants are instructed to trace a red dot along the outline of star shape using a 
computer mouse that is programmed to move the dot in the opposite direction. To increase 
distress, aversive auditory feedback (i.e., buzzer sound) is presented through headphones each 
time the participant moves the red dot outside of the star or stalls for longer than 2 seconds, and 
in such cases, the participant has to once again trace the star shape from the beginning. Four 
phases of the task are administered, which increase in difficulty as the participant progresses 
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through the four rounds. In the initial, easy phase, participants are asked to move the red dot 
along a star with a wide border until the tracing is complete. This level lasts for two minutes and 
difficulty level is titrated such that once the participant completes a star tracing, the border of the 
next star decreases in width until the allotted two minutes have elapsed. The next level of the 
task lasts for two minutes, and skill level during this phase of the task is dependent on participant 
performance in the first phase of the task. The same general procedure is used in the third phase 
of the task; however, the star’s line width is calibrated to a difficulty level that exceeds the 
participant’s performance on the previous round. This level lasts for one minute and is intended 
to induce distress. In the final phase, participants are shown a star identical to the one presented 
in the third phase, but unlike the previous phases, participants are given the option to end the task 
at any time by pressing a key on the computer keyboard. At the same time, participants are 
reminded that performance on this final phase dictates how much money they receive for study 
participation. All participants work independently on the task until voluntary task termination 
during the final phase or until the task self-terminates at the maximum 7-minute time limit. 
Behavioral DT was calculated as the latency (in minutes) to task termination on the final phase 
of this task.  
Distress Tolerance Scale (DTS; Simons & Gaher, 2005)  
The DTS, a 15-item self-report measure assessing beliefs about feelings of distress, was 
administered to assess perceived DT in the proposed study. Individuals rated their degree of 
agreement with a series of statements using a 1-5 Likert scale with 1 indicating strong agreement 
and 5 indicating strong disagreement with each statement. The DTS consists of several subscales 
including perceived ability to tolerate distress (Tolerance subscale; e.g., “Feeling distress or 
upset is unbearable to me”), the individual’s subjective appraisal of distress (Appraisal subscale; 
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e.g., “My feelings of distress or being upset are not acceptable”), how much attention is absorbed 
by the distress (Absorption subscale, e.g., “My feelings of distress are so intense that they 
completely take over”), and effort expended to alleviate distress (Regulation subscale, e.g., “I’ll 
do anything to avoid feeling distressed or upset”). Scores on items in each subscale were meaned 
to create each subscale score. Subscale scores were then averaged to yield a DTS mean item 
score. The DTS demonstrated good internal consistency in the current study (α > .88 across all 
assessment time points), which is in line with previous studies (e.g., Hasan et al, 2015; Leyro, 
Bernstein, Vujanovic, McLeish, & Zvolensky, 2011; Vujanovic et al., 2017).  
Timeline Follow-Back (TLFB; Sobell, Maisto, Sobell, & Cooper, 1979) 
The TLFB is an interviewer-administered measure assessing substance use in calendar 
format. An interviewer guides participants through recollection of day-by-day substance use in 
reverse order, beginning with the current assessment date and working backwards until the time 
of last assessment. The interviewer prompts participant’s recollection of use with meaningful 
events such as birthdays, payday, weekend festivities and holidays that may have occurred over 
the time interval in question. This measure demonstrates high test-retest reliability, convergent 
and discriminant validity, and agreement with collateral reports of substance use and urinalyses 
(Fals-Stewart, O'farrell, Freitas, McFarlin, & Rutigliano, 2000). Data acquired from the TLFB 
was used in the current study to determine 1) abstinence duration, defined as the number of 
weeks from pre-treatment assessment until first substance use and 2) frequency of substance use, 
defined as the percent of substance use days in the total days occurring between assessment time 
points, specifically between pre-treatment and residential discharge (T1-2), residential discharge 
and 3-months post-treatment (T2-3), 3-months and 6-months post-treatment (T3-4), and 6-months 
and 12-months post-treatment (T4-5). Participants who attrited prior to first use were 
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conservatively considered relapsed, and in those cases abstinence was coded as the time elapsed 
between pre-treatment and the last attended assessment. For individuals who remained abstinent 
throughout the study period, abstinence was coded as the time elapsed between pre-treatment 
(T1) and 12-month post-treatment (T5) assessments.  
Statistical Analysis 
 Perceived and behavioral DT trajectories from pre-treatment (T1) to 12-months post-
treatment (T5) were assessed separately using latent curve models (LCMs). LCM is a particularly 
useful analytic tool for large data sets with partially missing data that provides higher levels of 
statistical power than are available with traditional longitudinal analytic methods (e.g., repeated 
measures analysis of variance). In addition, LCM can accommodate unequal spacing between 
time points and allow for the inclusion of both time-invariant and time-varying predictors 
(Bollen & Curran, 2006).  The LCM framework typically includes intercept and slope factors 
(collectively called growth factors), whose means define the estimated average trajectory of a 
sample outcome.  Variability in these growth factors can also be examined to understand 
individual differences in the shape of change over time.  
The analysis proceeded in several stages. First, we performed preliminary analyses to 
characterize the sample, identify violations of normality, and visualize patterns of change in the 
data.  Next, given the sample size of the current study, we assessed statistical power of LCM to 
detect effects using a Monte Carlo simulation study. Additionally, because the DTS is a multi-
item measure consisting of multiple subscales, longitudinal measurement invariance was 
evaluated specifically for this measure to verify that subscales of the DTS represent the same 
latent constructs across all time points (Horn & McArdle, 1992). However, it was not necessary 
  
 
 
10 
to evaluate measurement invariance for behavioral DT, as the measure used was persistence 
time, a “one-item” behavioral variable.  
To determine the functional form of change in DT, a series of nested LCMs were fit to 
the data for both perceived and behavioral DT. First, we tested an intercept-only model that 
implied no change in DT in the sample over the study timeframe. Second, a linear slope factor 
was added to the model to allow for linear change in the outcome over follow-up. This linear 
slope model was compared to the intercept-only model using a likelihood ratio test (i.e., chi-
square difference), and the slope factor was retained significant improvement was observed in 
model fit. Finally, a freed loading slope factor was tested, which allows for non-linear growth in 
the outcome across study waves (Bollen & Curran, 2006).  Specifically, the loadings of the 
observed indicators on this slope factor are fixed to 0 and 1 for the first and last waves (i.e., T1 
and T5 respectively), and freely estimated for all other measurement occasions (i.e., T2, T3, and 
T4).  The freed loading model provides a flexible way to test for non-linear growth while 
conserving parsimony by estimating fewer parameters than more traditional non-linear models 
(e.g., quadratic latent curve models; Bollen & Curran, 2006). As above, the freed loading slope 
factor was retained if results of a chi-square difference test indicated that including such a factor 
significantly improved model fit when compared to the linear slope model. Once the functional 
form of change was ascertained for perceived and behavioral DT, a final model was tested 
constraining time-specific residual variances of the DT indicators to equality over time in an 
effort to maximize model parsimony. If this restricted model did not result in significant 
decrement in model fit, it was retained and interpreted as the final model of DT change. 
However, if equality constraints resulted in significantly poorer fit, residual variance terms were 
freely estimated at all time points. All models were compared with respect to chi-square 
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goodness of fit, the comparative fit index (CFI; Bentler, 1990), the Tucker-Lewis Index (TLI; 
Tucker & Lewis, 1973), the root-mean square error of approximation (RMSEA; Browne & 
Cudeck, 1993), and standardized root-mean-square residual (SRMR; Bentler, 1995). Acceptable 
fit was determined based on recommended guidelines (Hu & Bentler, 1999). 
 Finally, we examined the effect of substance use on the DT trajectory using two separate 
conditional LCMs based on the best-fitting unconditional models of perceived and behavioral 
DT. The conditional first model assessed the association between DT growth factors and 
abstinence duration, which served as a time-invariant covariate in the analysis This allowed us to 
preliminarily test the hypothesis that DT would continually improve over time without the 
influence of substances. However, as relatively few individuals maintain abstinence post-
treatment (McLellan, Lewis, O’Brien, & Kleber, 2000; National Institute on Drug Abuse, 2012), 
it is useful to consider alternative indices, such as substance use severity. Thus, a second model 
was used to investigate the impact of a time-varying covariate, frequency of use between each 
assessment time point, on time-specific fluctuations in DT. Utilizing this conceptualization not 
only allowed us to quantify amount of substance use but also aided in conserving statistical 
power when compared to binary measurement approaches of use historically used in treatment 
outcome research (Fitzmaurice, Lipsitz, & Weiss, 2017). Specifically, we regressed the observed 
DT variables at each post-treatment wave (i.e., T2-T5) on a time-specific covariate that 
represented the percentage of days within the interval since the last assessment during which 
participants had used substances (i.e., percent days used from T1-2, T2-3, T3-4, and T4-5). Thus, for 
instance, the observed DT indicator at 3-months post-treatment (T3) was regressed on a covariate 
reflecting the percentage of substance use days for the period between residential discharge (i.e., 
T2) and 3-months post-treatment (T3).  In addition, we included lagged paths between frequency 
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of use and subsequent observed DT indicators to assess the impact of prior use on future DT. All 
paths were freely estimated for the time-varying covariate at contiguous and subsequent 
assessment waves to account for the continuity in drug use over the study timeframe. A final 
model constraining regressions of observed indicators on the time-varying covariates was tested 
to maximize parsimony. If model fit was significantly degraded by this imposed constraint, a 
model with freely estimated regression paths was retained and interpreted.  
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CHAPTER 3: RESULTS 
Preliminary Analyses 
 Associations between sample characteristics and DT at pre-treatment are reported in 
Table 1.  
Table 1. Associations of participant characteristics and DT at pre-treatment. 
 DTST1 MTPT-CT1 
Age r = -0.07 r = 0.03 
Sex t(260) = 3.50** t(254) = 3.41** 
Education t(260) = -2.46* t(254) = -1.27 
Employment t(260) = -1.51 t(254) = -0.43  
Treatment Condition t(260) = -1.00 t(254) = 0.24 
Alcohol Dependence t(250) = 2.02* t(244) = -0.04 
Cannabis Dependence t(249) = -0.34 t(243) = 0.20 
Cocaine Dependence t(250) = 2.27* t(244) = 2.04* 
Opioid Dependence t(249) = -0.72 t(243) = -0.61 
Hallucinogen Dependence t(248) = -0.94 t(242) = 0.44 
Sedative Dependence t(249) = 0.15 t(243) = -0.02 
Note: r = Pearson correlation; t = independent samples t-test statistic; p < .05 = *, p 
< .01 = **, p < .001 = *** 
 
 Both gender and cocaine dependence were significantly associated with pre-treatment 
perceived and behavioral DT, while education and alcohol dependence were associated with pre-
treatment perceived, but not behavioral, DT. Means, standard deviations, and bivariate 
correlations between repeated measures of behavioral and perceived DT are presented in Table 
2.  
Table 2. Means, Standard Deviations, and Bivariate Correlations Among Repeated Measures of DT. 
 
 Mean SD DTST1 DTST2 DTST3 DTST4 DTST5 MTPT-CT1 MTPT-CT2 MTPT-CT3 MTPT-CT4 
DTST1 2.90 .89 --         
DTST2 3.09 .87 .54*** --        
DTST3 3.12 .87 .39*** .38*** --       
DTST4 3.08 .94 .43*** .60*** .35*** --      
DTST5 3.22 .86 .38*** .48*** .33** .46*** --     
MTPT-CT1 3.75 2.8
2 
.10 .02 .05 .14* .004 --    
MTPT-CT2 4.51 2.8
0 
.13* .17* .11 .07 -.03 .45*** --   
MTPT-CT3 4.23 2.8
1 
.16* .11 .06 .02 -.04 .36*** .57*** --  
MTPT-CT4 4.66 2.7
9 
.20** .12 -.01 .12 .06 .32*** .44*** .65*** -- 
MTPT-CT5 4.67 2.7
7 
.22** .13 .11 .04 .10 .31*** .46*** .63*** .69*** 
Note: DTS = Distress Tolerance Scale; MTPT-C = Mirror Tracing Persistence Task- Computerized Version (persistence time in 
minutes); SD = Standard Deviation; T1 = pre-treatment assessment; T2 = residential discharge assessment; T3 = 3-month follow-
up assessment; T4 = 6-month follow-up assessment; T5 = 12-month follow-up assessment; p < .05 = *, p < .01 = **, p < .001 = 
*** 
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 Significant positive correlations were observed within both perceived (r range: .33 to .60) 
and behavioral DT (r range: .31 to .69) over time. In contrast, concurrent measures of perceived 
and behavioral DT were generally small and not statistically significantly different from 0 
(absolute values of r range from .004 to .22). In addition, inspection of descriptive statistics and 
normality plots revealed a ceiling effect for behavioral, but not perceived, DT indicating that a 
high percentage of participants persisted without quitting on the final phase of the MTPT-C at 
each time point (T1=33.1%, T2 = 42.2%, T3 = 30.4%, T4 = 39.5%, T5 = 37.3%). The 
Kolmogorov-Smirnov (KS) test of normality was used to investigate distributions of all repeated 
measures of MTPT-C. Results of this test indicate significant deviation from normality at each 
time point (KSt1 = .19, KSt2 = .30, KSt3 = .25, KSt4 = .31, KSt5 = .31). Thus, a robust maximum 
likelihood estimator was used to estimate the change trajectory of behavioral DT to account for 
non-normality observed in the data (Muthen & Muthen, 2010). 
Power analysis  
Data were generated for this a priori simulation study using suggested values for 
intercept and slope factor variances, intercept and slope factor covariance, and residual variances 
of continuous outcomes (Muthen & Muthen, 2002). For the perceived DT simulation, a 
population estimate of 3.00 was used as the intercept growth factor mean based on previous work 
examining single time point DTS scores among treatment seeking substance users (Allan et al., 
2015; Hsu, Collins, & Marlatt, 2013, Magidson et al., 2013). The behavioral DT population 
estimate for the intercept growth factor mean was based on average persistence time of 3.50 
minutes on the MTPT-C in prior studies of substance users (Daughters et al., 2005; Daughters, 
Sargeant, Bornovalova, Gratz, & Lejuez, 2008; Daughters et al., 2009). In both perceived and 
behavioral DT simulations, the population estimate for the slope factor mean was tested at both 
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0.20 (small standardized effect) and 0.50 (medium standardized effect). In addition, both models 
were generated assuming missing data. Because this study uses previously collected data, the 
probability of missing data was calculated and specified for each measurement occasion. Models 
were estimated by maximum likelihood for normally distributed data (i.e., DTS) and robust 
maximum likelihood for non-normally distributed data (i.e., MTPT-C). 
Results of the Monte Carlo simulation studies for models where population slope mean 
estimates were set at 0.20 revealed that a linear latent growth model was adequately powered to 
detect intercept and slope effects (power = 1.00 for both intercept and slope) for both behavioral 
and perceived DT.  A nonlinear model with freed factor estimates was also adequately powered 
to detect the intercept and slope effects for both behavioral and perceived DT outcomes 
(intercept: power = 1.00; slope: power = .87 and .76 for perceived and behavioral DT 
respectively). Alternatively, when using a medium effect size (0.5) for population slope mean 
estimates, both linear and freed factor loading models were well powered to detect mean latent 
intercept (power = 1.00) and slope factors (power > .99) for both behavioral and perceived DT.  
Longitudinal Measurement Invariance of DTS 
 We evaluated DTS measurement invariance in a series of three nested models. First, a 
configural invariance model, in which a unidimensional factor structure for the 15 DTS items 
was specified at each assessment wave, demonstrated good fit to the data (χ 2(120) = 239.74, p < 
.001; CFI = .96; TLI = .93, RMSEA = .06, SRMR = .05).  This result suggested consistency in 
the latent structure of perceived DT over time. Next, we tested a weak invariance model by 
constraining DTS factor loadings to equality over time. This model fit the data equally as well as 
the unrestricted configural invariance model, Δχ 2(12) = 20.02, p = .07, verifying that DTS 
indicators had equivalent associations with the latent DT construct over time. Finally, a strong 
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invariance model was tested by restricting both factor loadings and intercepts to be invariant over 
time. This model produced a significant decrement in fit when compared to the weak invariance 
model, Δχ 2(12) = 25.58, p = .01. Inspection of modification indices revealed that constraints 
associated with strong invariance were particularly problematic for the DTS regulation subscale 
assessed at the second study wave (T2). This model was re-specified after freeing the equality 
constraint on this item. This model fit equally well when compared to the weak invariance 
model, Δχ 2(11) = 15.14, p = .18, supporting partial strong invariance for the DTS. Overall, this 
series of analyses justifies use of a LCM to interpret perceived DT change over time as measured 
by DTS.    
Unconditional Models of Perceived and Behavioral DT  
Model comparison  
Concerning perceived DT, an intercept-only model was first tested and showed poor fit to 
the data, χ2(13) = 45.53, p < .001; CFI = .89; TLI = .92; RMSEA = .10; SRMR = .14. Next, a 
linear growth model was tested and demonstrated significantly improved (Δχ2(3) = 18.41, p < 
.001) but not optimal fit, χ2(10) = 27.12, p < .01; CFI = .94; TLI = .94; RMSEA = .08; SRMR = 
.10. To test for a non-linear growth trajectory, a freed loading latent growth model was fit to the 
data, and demonstrated significant improvement over the linear growth model (Δχ2(3) = 9.65, p < 
.05) and good model fit overall, χ2(7) = 17.47, p < .01; CFI = .97; TLI = .95; RMSEA = .08; 
SRMR = .09. Finally, we tested a freed factor loading model with equality constraints imposed 
on time specific residuals, but this model produced a significant decrement in fit, Δχ2(4) = 9.72, p 
< .05. Thus we retained the freed loading model with freely estimated residuals as the final 
perceived DT model.  
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The same sequence of model comparisons was conducted for behavioral DT using a 
robust maximum likelihood estimator to account for non-normality in the data. The intercept-
only model showed poor fit to the data χ2(13) = 68.53, p < .001; CFI = .77; TLI = .82; RMSEA = 
.13; SRMR = .12. The linear growth model demonstrated significantly improved (Satorra-
Bentler Scaled Δχ2(3) = 35.61, p < .001), but not optimal fit to the data, χ2(10) = 32.99, p < .001; 
CFI = .90; TLI = .90; RMSEA = .09; SRMR = .07. Thus, the freed loading model was tested and 
led to a significant improvement on the linear LCM (Satorra-Bentler Scaled Δχ2(3) = 17.28, p < 
.001) and good fit to the data overall, χ2(7) = 15.37, p = .03; CFI = .97; TLI = .95; RMSEA = 
.07; SRMR = .05. Constraining the observed indicator residual variances to equality significantly 
degraded model fit (Satorra-Bentler Scaled Δχ2(4) = 13.25, p = .01) so this restriction was 
rejected, and the freed loading model with freely estimated residuals was retained as the final 
behavioral DT model. Final models for both perceived and behavioral DT are displayed in 
Figure 1.
Figure 1. Latent growth curve model examining change trajectory of perceived and behavioral DT. 
 
 
 
Note: MTPT-C = Mirror Tracing Persistence Test -Computerized Version; DTS = Distress Tolerance Scale; T1 = pre-treatment 
assessment; T2 = residential discharge assessment; T3 = 3-month follow-up assessment; T4 = 6-month follow-up assessment; T5 = 
12-month follow-up assessment 
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Parameter estimates 
Observed and model estimated means of perceived and behavioral DT are displayed in 
Figure 2a-b. 
Figure 2a-b. Observed and model estimated sample means for (a) perceived DT estimated 
using total DTS scores and (b) behavioral DT estimated using task persistence time in 
minutes on the MTPT-C. Both figures show sample means (observed and model estimated) 
from DT repeated measures administered at five time points from pre-treatment to 12-
months post-treatment. 
 
 
Note: DT = Distress Tolerance; DTS = Distress Tolerance Scale; MTPT-C = Mirror Tracing 
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Additionally, unstandardized factor loadings and parameter estimates from the final 
unconditional freed loading model of both perceived and behavioral DT are presented in Table 
3.  
Table 3. Unstandardized factor loadings and parameter estimates from unconditional 
latent curve models of perceived and behavioral DT. 
 
 
Factor loadings for the first (T1) and last (T5) assessment waves were set to 0 and 1 
respectively to capture total DT change over the 12-month study period. The unstandardized 
loadings of the intervening waves (T2-4) can be interpreted as a percentage that represents the 
proportion of change occurring between two time points relative to total change occurring 
between first and last time points (McArdle, 1988). As shown, the majority of improvement in 
both perceived and behavioral DT occurred between pre-treatment (T1) and residential discharge 
(T2) assessments (51% and 55%, respectively). Slope factor means reflecting the expected 
change in DT from the first to final assessment waves (T1 to T5) indicate that both perceived and 
Parameter Perceived DT (DTS) Behavioral DT (MTPT-C) 
Factor Loadings: Slope   
     T1 0 (0) 0 (0) 
   
     T2 0.51 (0.16)** 0.55 (0.13)*** 
     T3 0.65 (0.17)*** 0.78 (0.12)*** 
     T4 0.64 (0.20)** 0.97 (0.09)*** 
     T5 1 (0) 1 (0) 
Mean   
     Intercept 2.91 (0.06)*** 3.79 (0.19)*** 
     Slope 0.31 (0.07)*** 0.81 (0.22)*** 
Variance   
     Intercept 0.48 (0.09)*** 4.93 (1.09)*** 
     Slope 0.25 (0.16) 5.80 (1.65)*** 
Intercept-Slope r -0.52 (0.14)*** -0.49 (0.13)*** 
Note: Standard errors are displayed in parentheses; DT = Distress Tolerance; DTS = Distress 
Tolerance Scale; MTPT-C = Mirror Tracing Persistence Task- Computerized Version; T1 = pre-
treatment assessment; T2 = residential discharge assessment; T3 = 3-month follow-up assessment; 
T4 = 6-month follow-up assessment; T5 = 12-month follow-up assessment; p < .05 = *, p < .01 = **, 
p < .001 = *** 
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behavioral DT exhibit a significant propensity to increase nonlinearly over time (ps < .001). 
Furthermore, significant variance in perceived and behavioral DT intercept factors indicate 
significant individual differences in DT at pre-treatment (T1), given that the variance of the 
intercept factor reflects the estimated variability of the outcome at T1. Significant variance in the 
behavioral, but not perceived, DT slope factor indicates significant inter-individual variability in 
behavioral DT change over follow up. Finally, significant negative correlations between both 
perceived and behavioral DT intercept and slope factors indicate greater DT improvement over 
time among individuals with low pre-treatment DT. Overall, these models explain 39-59% and 
46-70% of the variance in time-specific measurements of perceived and behavioral DT 
respectively (all ps < .001).  
Conditional Models of Perceived and Behavioral DT 
Figure 3 shows two conditional latent growth models for perceived and behavioral DT. The first 
examined abstinence duration (red) and the second examined frequency of use (blue) as potential 
predictors of interest.  
Figure 3. Latent growth curve model examining the association of weeks to first use (red) and the influence of time-specific 
percentage of days used (blue) on the change trajectory of perceived and behavioral DT. 
 
 
 
 
 
 
 
 
 
 
Note: DT = Distress Tolerance; MTPT-C = Mirror Tracing Persistence Test -Computerized Version; DTS = Distress Tolerance Scale; 
T1 = pre-treatment assessment; T2 = residential discharge assessment; T3 = 3-month follow-up assessment; T4 = 6-month follow-up 
assessment; T5 = 12-month follow-up assessment 
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Time-Invariant Covariate: Abstinence Duration 
The conditional model estimating the association between abstinence duration and 
perceived DT trajectory demonstrated adequate fit to the data, χ2(10) = 20.65, p = .02; CFI = .97; 
TLI = .95; RMSEA = .06; SRMR = .09. Abstinence duration was significantly associated with 
the perceived DT slope factor (β = .24; b = 0.006, SE = 0.003, p < .05), but not intercept factor (β 
= -.01; b = 0.001, SE = 0.003, p = .91). Similarly, the conditional model estimating the 
association between abstinence duration and the trajectory of behavioral DT fit the data well, 
χ2(10) = 19.95, p = .03; CFI = .96; TLI = .95; RMSEA = .06; SRMR = .05. Abstinence duration 
was significantly associated with the behavioral DT slope factor (β = .20, b = .02, SE = .01, p = 
.02) but not intercept (β = -.15, b = -.02, SE = .01, p = .06). Results of both models are 
graphically displayed in Figure 4a-b, with abstinence duration broken down into 4 weeks (1 
month), 26 weeks (6 months), and 52 weeks (12 months) for ease of interpretation. As 
demonstrated, abstinence duration is positively associated with the perceived (Figure 4a) and 
behavioral (Figure 4b) DT trajectory, such that longer periods of abstinence are associated with 
greater increases in DT over time. 
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Figure 4a-b. Model estimated trajectory of (a) perceived DT and (b) behavioral DT at 
specified levels of abstinence duration, a time-invariant predictor. Specifically, the figure 
shows both perceived and behavioral DT latent trajectory when abstinence duration is 
equal to 4 weeks (1 month), 26 weeks (6 months), and 52 weeks (12 months). 
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Time-varying Covariate: Frequency of use   
Finally, we tested a LCM with the percentage of days (over follow-up) on which 
participants used substances serving as a time-varying covariate in the perceived DT model. The 
initial model fit approached adequate fit, χ2(12) = 26.61, p < .01; CFI = .95; TLI = .88; RMSEA 
= .07; SRMR = .06. To conserve parsimony, regressions of observed indicators on the time-
varying covariates were constrained to equality and did not result in significant degradation of 
model fit, Δχ2(5) = 4.91, p = .43. This model fit the data well, χ2(17) = 31.52, p < .02; CFI = .95; 
TLI = .92; RMSEA = .06; SRMR = .06, and revealed that frequency of use was not significantly 
related to DTS scores (i.e. perceived DT) at concurrent (b = .03, SE = .22, p = .89) nor 
subsequent (b = -.01, SE = .16, p = .97) measurement occasions.  
 Analysis steps were next replicated using the behavioral DT model. The conditional 
LCM with percent days used as a time-varying covariate approached adequate fit to the data 
χ2(12) = 31.30, p < .01; CFI = .95; TLI = .86; RMSEA = .08; SRMR = .04. Regressions of 
observed indicators on the time-varying covariates were constrained to equality to conserve 
model parsimony and did not result in significant degradation of model fit, Satorra-Bentler 
Scaled Δχ2(5) = 9.14, p = .10. This model was thus retained, and results revealed that higher 
percent days used significantly predicted lower MTPT-C scores (i.e. lower behavioral DT) at 
concurrent (b = -1.12, SE = .47, p < .02) but not subsequent assessment occasions (b = .24, SE = 
.53, p = .65).  
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CHAPTER 4: DISCUSSION 
 The current study examined the trajectory of distress tolerance among substance users 
receiving residential treatment over a series of five assessment waves occurring intermittently 
from pre-treatment to 12-months post-treatment and investigated the relationship between DT 
change over time and both abstinence duration and severity of substance use post-treatment. As 
predicted, both behavioral and perceived DT improved over time, such that substance users 
evidenced increased persistence time on a distressing behavioral task, and rated self-reported 
ability to tolerate distress as generally increasing, from pre-treatment to 12-months post-
treatment. In addition, abstinence duration post-treatment was positively associated with both 
perceived and behavioral DT such that individuals who were able to maintain longer periods of 
abstinence post-treatment evidenced greater improvements in perceived and behavioral DT. 
Moreover, greater frequency of use between post-treatment assessment waves was associated 
with attenuated improvement in post-treatment behavioral DT. Contrary to expectation, this 
association was not observed for perceived DT change.  
 This study is the first to provide evidence for naturally occurring DT change over time. 
Though initial evidence supports the efficacy of DT-targeted treatment in improving DT among 
varying substance using populations (e.g., Bornovalova et al., 2012; Brown et al., 2014), this 
study suggests that DT may improve organically over time specifically within this population, as 
the participants in this trial did not receive treatment targeting distress tolerance (Daughters et 
al., 2017). The rate of DT change was best characterized as non-linear, suggesting that the rate of 
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DT change itself changes over time. One explanation may be the influence of environmental 
factors on an individual’s perceived and actual ability to improve DT over time. For example, as 
demonstrated in this study more than half of the total increase in both perceived and behavioral 
DT occurred while participants were in the restricted environment of residential treatment, 
between T1 (treatment entry) and T2 (residential treatment discharge). We observe fluctuations in 
the rate of DT improvement among substance users after treatment discharge, between T2 and T5, 
when environmental factors between participants were no longer held constant. In particular, 
housing and financial stability, employment, social networks, and acute stressors, that are known 
to influence the course of recovery for substance users (Davies, Elison, Ward, & Laudet, 2015; 
Sinha, 2007; Walton, Blow, Bingham, & Chermack, 2003; Worley, Witkiewitz, Brown, 
Kivlahan, & Longabaugh, 2015) may also have influenced DT trajectories.  
Relatedly, we found significant variance in the behavioral DT slope factor specifically, 
suggesting that not only does the rate of change in DT vary over time, but that differences in 
overall behavioral DT trajectories exist among substance users. Individual differences in both 
perceived and behavioral DT at pre-treatment have been investigated in previous studies, 
revealing relationships between DT and gender (Ali, Seitz-Brown, & Daughters, 2015; Burjarski, 
Norberg, & Copeland, 2012; Daughters et al., 2009; Tull et al., 2013), and co-occurring 
psychopathology (Ali, Seitz-Brown, & Daughters, 2015; Gorka, Ali, & Daughters, 2012; Tull et 
al., 2013). These associations have also been linked to treatment efficacy and outcome among 
substance users specifically (e.g., Daughters et al., 2009; Gorka, Ali, & Daughters, 2012). 
However, no study has investigated individual difference factors in relation to behavioral or 
perceived DT change over time in this population. Though such work is outside the scope of the 
current study, the association of pre-treatment DT with sample characteristics such as gender and 
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specific substance dependence diagnoses reported here (Table 1) provide additional evidence 
supporting the importance of future studies identifying additional predictors of DT trajectories to 
further elucidate nuanced variation in DT change.  
In the current study, we were specifically interested in examining the influence of 
substance-related predictors of DT change, namely abstinence and severity of use post-treatment. 
As predicted, sustained abstinence was associated with greater improvements in both perceived 
and behavioral DT. This is consistent with findings showing that sustained abstinence allows for 
recovery of cognitive and affective processes as well as changes in underlying neurobiological 
structure and function related to DT (Fox, Hong, & Sinha, 2008; Fox et al., 2007; Garavan, 
Brennan, Hester, & Whelan, 2013; Schmidt, Pennington, Cardoos, Durazzo, & Meyerhoff, 2017; 
Tull, Schulzinger, Schmidt, Zvolensky, & Lejuez, 2007; Wang et al., 2012).  In addition, we 
found that greater post-treatment frequency of use was associated with attenuated behavioral DT 
such that participants who used more frequently between assessment waves were unable to 
persist on a distressing task for as long as those who used less frequently, if at all, during the 
study period. Research indicates that impairment in cognitive function is associated with acute 
and chronic substance use (Broyd, van Hell, Beale, Yucel, & Solowij, 2016; Everitt & Robbins, 
2016; Volkow et al., 2016), and may be exacerbated by increased rates of use (Grant & 
Chamberlain, 2014; Vonmoos et al., 2014). In addition, evidence suggests that prior heavy use 
predicts future avoidance behavior and decreased problem solving (Weiss, Bold, Sullivan, 
Armeli, & Tennen, 2016). Contrary to hypotheses, we did not find a relationship between 
frequency of substance use and perceived DT change. Theoretical perspectives posit that 
substance users in particular not only evidence impaired cognitive and behavioral functioning, 
but additionally lack insight and self-awareness as a by-product of substance use (Goldstein et 
  
 
 
30 
al., 2009). Thus it may be that individuals who used substances post-treatment were unable to 
realize the impact of use on current functioning, particularly when evaluating DT. Additional 
research is needed to understand discrepancies between perceived and behavioral DT within this 
population more specifically and the implications of this disconnect on future functioning. 
Nonetheless, findings from the current study lend support to this work and suggest that 
abstinence allows for recovery of DT while substance use has acute and temporally-specific 
effects on behavioral DT in particular, providing preliminary evidence for the malleability and 
sensitivity of DT to proximal psychological and biological events.  
Though findings from this study are both novel and important, there are several 
limitations to consider. First, sample size limits our ability to test for the effects of predictors of 
DT change over time using a LCM approach. For example, simulation studies conducted by 
Muthen and Muthen (2002) indicate that the addition of a covariate in a latent growth model 
significantly increases the sample size necessary to detect effects. As such, we selectively 
included only two covariates—substance use frequency and abstinence duration—as predictors 
of DT change in the present study due to their theoretical relevance, and did not evaluate 
additional potential covariates in relation to current study aims. Additionally, though we 
examined the relationship between substance use variables and DT change, we were unable to 
establish definite temporal precedence of abstinence duration and frequency of use in the current 
study. First, abstinence duration was included in the LCM as a time-invariant covariate, and as 
such, we were limited to interpreting the association between abstinence and DT change, but 
could not evaluate the predictive utility of abstinence on such change. Additionally, frequency of 
use was associated with behavioral DT measured at concurrent, but not subsequent, assessment 
occasions. For example, we found that substance use occurring between treatment discharge and 
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three months post-treatment was associated with attenuated behavioral DT at three-months post-
treatment but was not related to DT at six months post-treatment. One explanation for the null 
findings of lagged effects may be the large and variable temporal spacing between assessment 
waves. It may be that substance use behavior has a more immediate effect on DT than could be 
determined in the current study. Thus, future studies assessing DT and substance use behavior at 
more frequent intervals post-treatment may be needed to disentangle temporal relationships 
between substance use and DT change.  Finally, the results of the current study reflect the impact 
of substance use on DT change among a primarily African American sample of residential 
treatment seeking substance users, limiting the generalizability of study findings. One future 
direction may be to replicate the current study in other populations, including those from varying 
racial and ethnic backgrounds, and even non-treatment-seeking substance users or individuals in 
alternative treatment settings. 
Nevertheless, findings from the current study provide important information currently 
lacking in the DT literature. First, we demonstrated that both perceived and behavioral DT 
exhibit organic, temporal fluctuations even in the absence of targeted treatment. In general, the 
temporal stability of the DT construct has been discussed extensively among DT researchers 
(Leyro, Zvolensky, & Bernstein, 2010) and this study is the first to provide evidence for natural 
change in both perceived and behavioral conceptualizations of DT among substance users. In 
addition, by identifying important predictors of this change, we demonstrated both perceived and 
behavioral DT are sensitive to proximal biological and psychological events. Such situational 
factors are important to consider in the context of substance use treatment. For example, as 
higher DT serves as a protective factor against poor treatment outcomes among substance users 
(Brown, Lejuez, Kahler, & Strong, 2002; Cameron, Reed, & Ninnemann, 2013; Daughters, 
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Lejuez, Kahler, Strong, & Brown, 2005; Strong et al., 2012), prioritizing abstinence duration in 
current treatment models may allow for natural improvements in DT to occur, and thus improve 
rates of substance use recovery. Finally, study findings, which support the conceptualization of 
DT as a malleable treatment target, lend support for continued investigation into the efficacy and 
implementation of DT-targeted treatment, and emphasize the potential utility of DT-focused 
treatment among substance users. In conclusion, this study provides the foundation for future 
research to evaluate DT change as a protective factor among treatment seeking substance users, 
which may lead to improved outcomes among those suffering from a substance use disorder. 
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